Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 10/10/26
Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 10/09/26
Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 10/08/26
Bristol Myers Squibb's Zenbexus Delivers Major Blood Cancer Win, Cuts Progression Risk 51%Benzinga • 10/08/26
Bristol Myers Squibb Announces ZENBEXUSTM (iberdomide) in Combination with Daratumumab and Dexamethasone (ZDd) Demonstrates Superior Progression-Free Survival vs.Business Wire • 10/08/26
Bristol-Myers Squibb: Balanced Segment Growth, The Pullback Is An OpportunitySeeking Alpha • 10/07/26
5 Dividend Stocks With Fortress-Like Coverage and Room for Things to Go Wrong24/7 Wall Street • 10/07/26
3 Stocks With Broker Rating Upgrades Amid Resilient Equity MarketsZacks Investment Research • 10/05/26
Bristol Myers Squibb Now Trades at Only 9.4X Forward Earnings -- Is This Value Stock a Buy?The Motley Fool • 10/03/26
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 10/01/26
Bristol-Myers Squibb vs. Johnson & Johnson: Comparing Quarterly Revenue ScaleThe Motley Fool • 10/01/26
Bristol Myers Squibb Deepens Commitment to Healthcare Professionals Through Champions in Care MovementBusiness Wire • 10/01/26
U.S. Food and Drug Administration Approves Expanded Indication for Bristol Myers Squibb's CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) in Adults and Pediatric Patients*Business Wire • 09/30/26
Bristol Myers Squibb's Dividend Sustainability Hinges on One Critical Cash Flow Metric24/7 Wall Street • 09/30/26
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to KnowZacks Investment Research • 09/30/26
Bristol Myers Squibb vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 09/29/26
AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, MerckInvestors Business Daily • 09/29/26